Dr. ERIC HOLLAND is building a DATABASE OF GENETIC INFORMATION of patients’ tumors. When new patients have tumors profiled, doctors will be able to compare those profiles to others in the database and select treatments that give patients the chance at survival.
Approximately 1 in 4 cases of cancer is infection-related and most strike people in the developing world. As part of our program in GLOBAL ONCOLOGY, research teams at Fred Hutch and the Uganda Cancer Institute unite to create affordable, lifesaving treatments in a limited-resource setting.
Dr. JIM OLSON developed TUMOR PAINT, an experimental molecule derived from scorpion venom that illuminates cancer cells so surgeons can see the tumor margins more clearly.
Hundreds of CLINICAL TRIALS are underway at Fred Hutch — giving patients access to the newest treatments and helping our investigators develop effective therapies faster.
Drs. PHIL GREENBERG and STANLEY RIDDELL were among the first to show the potential of the immune system to wipe out cancers. Now we’re perfecting this approach, which could render chemotherapy and radiation obsolete through IMMUNOTHERAPY.
Drs. LARRY COREY and JULIE MCELRATH built the HIV VACCINE TRIALS NETWORK (HVTN), the world’s largest network for testing potential HIV VACCINES with promising trials underway in dozens of countries.
More than one million BONE MARROW TRANSPLANTS (BMT) have been performed worldwide — a testament to Fred Hutch's DR. E. DONNALL THOMAS, who pioneered the technique. Thomas' work earned him a Nobel Prize, 1 of 3 awarded to Hutch scientists since 1990. When the Hutch-based WOMEN'S HEALTH INITIATIVE, led by Drs. GARNET ANDERSON and ROSS PRENTICE, found combined hormone therapy dramatically increases breast cancer risk, millions of women stopped taking the drugs, preventing up to 20,000 cases of breast cancer every year in the U.S.
Dr. DENISE GALLOWAY helped develop a vaccine that prevents human papillomavirus (HPV) infection, which can cause cervical cancer. Her work means thousands of women worldwide avoid the deadly disease and, with low-cost HPV vaccines now being distributed in the developing world, many more lives will be saved.
Drs. SCOTT RAMSEY and GARY LYMAN formed HICOR (Hutchinson Institute for Cancer Outcomes Research) to work with patients, physicians, researchers and payers to identify the nexus of the most effective and affordable cancer care.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.